Source link : https://www.newshealth.biz/health-news/low-endocrine-therapy-adherence-for-breast-cancer-post-pregnancy/
TOPLINE: Among breast cancer survivors who became pregnant, 34% resumed endocrine therapy (ET) by 2 years postdelivery, with a 19% cumulative incidence of subsequent breast cancer events at 10 years. METHODOLOGY: The POSITIVE trial previously reported that women who interrupted ET for pregnancy, 73% resumed treatment with a low disease recurrence rate of 9%. The […]
Author : News Health
Publish date : 2025-02-13 16:00:00
Copyright for syndicated content belongs to the linked Source.